Jun 4, 2014

Availability of Biosimilar Pathways and Data/Marketing Exclusivity Globally

During the last several months, we expanded our research to gain a broader understanding of which countries provide biosimilar pathways and data and/or marketing exclusivity for innovator biologics. Presently, over 40 countries have biosimilar pathways.
back to top